Protecting Now From What Comes Next
Leyden Labs is a clinical-stage biotechnology company developing nasal sprays containing broadly-neutralizing antibodies that target respiratory viruses in the nasal mucosa. Their lead program PanFlu targets influenza A and B strains with a universal mechanism designed to protect against existing and future viral variants. Founded in 2020 and based in Leiden, Netherlands.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountOct 2025
Jan 2025
Jan 2022
Mar 2021
Jan 2021
Create a free account to see which investors have funded this company.
Create Free Account
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
South Korean biotech company and global leader in medical aesthetics, manufacturing botulinum tox...
Global full-service clinical research organization (CRO) and scientific advisory partner for biot...
Global clinical research organization specializing in early-stage clinical trials and bioanalytic...
Healthcare company applying technology to drug development by building nimble biotech subsidiarie...
Neuralink is building a brain-computer interface for medical needs and greater human potential.
